Outset Medical


ATLANTA, GA – – (July 25, 2022) – – Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM).  The lawsuit alleges Outset Medical made certain false and/or misleading statements and/or failed to disclose material information regarding the Company’s business, operations, and prospects, including: (1) that Defendants continuously updated its product, Tablo, which necessitated an additional 510(k) application; (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols; and (3) the Company’s inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a “shipment hold” and marketing suspension, leaving the Company unable to sell Tablo for home use. If you bought shares of Outset Medical between September 15, 2020, and June 13, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is September 6, 2022.

Registration Deadline

Lead Plaintiff Deadline Has Passed

September 6, 2022

Submit Your Information

Shares Purchased
Date Puchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date Sold
Number of Shares Sold
Selling Price Per Share
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.